Table of Contents

Download Journal

oncol_issue

Contributors

dr.s.verma
Shailendra Verma, MD, FRCPC, FACP
Medical oncologist with Cancer Care Ontario at The Ottawa Hospital Regional Cancer Centre (TOHRCC)
Assistant Professor, Department of Medicine, University of Ottawa
With an academic specialty in breast cancer, melanoma, and sarcoma, Dr. Verma chairs the disease site groups in each of these areas at the University of Ottawa, and is chair or a member of these groups at the provincial level. He is a principal investigator in numerous research and educational projects at the ORCC and the Ottawa Regional Women’s Breast Health Centre. He frequently presents papers on drug therapies for breast cancer and on breast cancer management, and speaks on breast cancer advocacy issues.

dr-krieger
Henry Krieger, MD
Hematologist/Oncologist, Scarborough Hospital
Dr. Krieger is a hematologist/oncologist at Scarborough Hospital, the General division. Scarborough Hospital is involved in clinical trials with NCIC and other industry funded trials. Dr. Krieger has maintained an active clinical practice for the last 31 years, and previously headed a community oncology group called COMET in the metro Toronto area for a number of years. He continues to be an active member of the group. He is also a member of ASCO, ASH and CAMO.

dr-laneuville
Pierre Laneuville, MD, FRCPC
Associate Professor of Medicine and Oncology, McGill University Division of Hematology, McGill University Health Centre
Royal Victoria Hospital, Montreal
President, Canadian Hematological Society

Chairman, Canadian Consensus Group on the Management of Chronic Myeloid Leukemia (CCGM-CML)
With an academic specialty in breast cancer, melanoma, and sarcoma, Dr. Verma chairs the disease site groups in each of these areas at the University of Ottawa, and is chair or a member of these groups at the provincial level. He is a principal investigator in numerous research and educational projects at the ORCC and the Ottawa Regional Women’s Breast Health Centre. He frequently presents papers on drug therapies for breast cancer and on breast cancer management, and speaks on breast cancer advocacy issues.